Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $118,144 | 60 | 49.2% |
| Consulting Fee | $84,534 | 36 | 35.2% |
| Travel and Lodging | $25,928 | 82 | 10.8% |
| Honoraria | $5,700 | 3 | 2.4% |
| Food and Beverage | $4,727 | 68 | 2.0% |
| Education | $974.53 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $89,726 | 72 | $0 (2024) |
| Lilly USA, LLC | $80,157 | 91 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $19,274 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $17,203 | 18 | $0 (2024) |
| Amgen Inc. | $13,387 | 5 | $0 (2024) |
| AstraZeneca UK Limited | $6,590 | 5 | $0 (2024) |
| Life Technologies Corporation | $5,922 | 3 | $0 (2024) |
| PFIZER INC. | $3,319 | 3 | $0 (2024) |
| GENZYME CORPORATION | $1,876 | 3 | $0 (2023) |
| Roche Diagnostics Corporation | $719.05 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78,860 | 71 | Lilly USA, LLC ($28,847) |
| 2023 | $33,176 | 38 | Janssen Biotech, Inc. ($13,703) |
| 2022 | $36,802 | 46 | Lilly USA, LLC ($29,706) |
| 2021 | $26,510 | 25 | Lilly USA, LLC ($15,123) |
| 2020 | $23,301 | 21 | Bayer HealthCare Pharmaceuticals Inc. ($19,694) |
| 2019 | $41,049 | 43 | Bayer HealthCare Pharmaceuticals Inc. ($40,391) |
| 2018 | $197.38 | 4 | Roche Diagnostics Corporation ($127.67) |
| 2017 | $114.11 | 2 | Merck Sharp & Dohme Corporation ($100.00) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| 12/17/2024 | Amgen Inc. | LUMAKRAS (Drug) | Consulting Fee | Cash or cash equivalent | $9,436.50 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Amgen Inc. | LUMAKRAS (Drug) | Consulting Fee | Cash or cash equivalent | $3,495.00 | General |
| Category: Oncology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $105.12 | General |
| Category: Oncology | ||||||
| 11/24/2024 | Life Technologies Corporation | — | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| 11/21/2024 | Roche Diagnostics Corporation | cobas 6000 Core Unit (Device) | Food and Beverage | In-kind items and services | $162.11 | General |
| Category: Centralized Diagnostics | ||||||
| 11/21/2024 | OXFORD GENE TECHNOLOGY INC | — | Food and Beverage | In-kind items and services | $36.30 | General |
| 11/19/2024 | Amgen Inc. | LUMAKRAS (Drug), Vectibix | Travel and Lodging | In-kind items and services | $332.05 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Amgen Inc. | Vectibix (Biological) | Food and Beverage | In-kind items and services | $95.25 | General |
| Category: Oncology | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $1,222.18 | General |
| 10/28/2024 | AstraZeneca UK Limited | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $6,050.00 | General |
| Category: Oncology | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,420.00 | General |
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $2,628.00 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $3,285.00 | General |
| Category: Oncology | ||||||
| 10/22/2024 | OXFORD GENE TECHNOLOGY INC | — | Honoraria | Cash or cash equivalent | $200.00 | General |
| 10/21/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| 10/21/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,025.00 | General |
| 10/16/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $868.48 | General |
| 10/16/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $205.25 | General |
| 10/16/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $194.25 | General |
| 10/16/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $162.87 | General |
| 10/16/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $27.07 | General |
| 10/16/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $1.77 | General |
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $103.15 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Lilly USA, LLC | — | Travel and Lodging | Cash or cash equivalent | $188.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,991 | 2,508 | $669,106 | $143,960 |
| 2022 | 9 | 1,994 | 2,812 | $771,750 | $161,541 |
| 2021 | 6 | 529 | 578 | $190,546 | $44,352 |
| 2020 | 7 | 327 | 781 | $194,283 | $35,108 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Office | 2023 | 42 | 82 | $119,146 | $30,734 | 25.8% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Facility | 2023 | 174 | 523 | $112,968 | $28,320 | 25.1% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2023 | 593 | 659 | $104,688 | $26,592 | 25.4% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Office | 2023 | 146 | 154 | $91,014 | $19,825 | 21.8% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Office | 2023 | 259 | 280 | $44,520 | $11,266 | 25.3% |
| 88381 | Preparation of specimen, manual | Facility | 2023 | 375 | 389 | $102,079 | $7,795 | 7.6% |
| 88381 | Preparation of specimen, manual | Office | 2023 | 38 | 38 | $28,310 | $7,239 | 25.6% |
| 88291 | Interpretation and report of genetic testing | Facility | 2023 | 157 | 170 | $23,290 | $4,864 | 20.9% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Facility | 2023 | 129 | 133 | $30,457 | $4,704 | 15.4% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 46 | 47 | $8,113 | $1,674 | 20.6% |
| 88291 | Interpretation and report of genetic testing | Office | 2023 | 32 | 33 | $4,521 | $947.10 | 20.9% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Office | 2022 | 50 | 87 | $126,411 | $33,022 | 26.1% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Facility | 2022 | 176 | 558 | $120,528 | $30,377 | 25.2% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2022 | 573 | 633 | $95,512 | $24,753 | 25.9% |
| 88121 | Cell examination of urine, computer-assisted | Office | 2022 | 43 | 45 | $85,365 | $17,217 | 20.2% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Office | 2022 | 115 | 120 | $70,920 | $14,867 | 21.0% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Office | 2022 | 205 | 226 | $34,198 | $9,108 | 26.6% |
| 88381 | Preparation of specimen, manual | Facility | 2022 | 394 | 413 | $108,619 | $8,414 | 7.7% |
| 88291 | Interpretation and report of genetic testing | Facility | 2022 | 161 | 176 | $24,112 | $5,127 | 21.3% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2022 | 12 | 276 | $38,640 | $4,976 | 12.9% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Facility | 2022 | 124 | 135 | $30,915 | $4,773 | 15.4% |
| 88381 | Preparation of specimen, manual | Office | 2022 | 24 | 24 | $16,103 | $4,506 | 28.0% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 71 | 73 | $12,775 | $2,616 | 20.5% |
| 88291 | Interpretation and report of genetic testing | Office | 2022 | 33 | 33 | $4,521 | $961.02 | 21.3% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2022 | 13 | 13 | $3,131 | $827.59 | 26.4% |
About Dr. Eric Vail, M.D
Dr. Eric Vail, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1609277649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Vail, M.D has received a total of $240,007 in payments from pharmaceutical and medical device companies, with $78,860 received in 2024. These payments were reported across 250 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($118,144).
As a Medicare-enrolled provider, Vail has provided services to 4,841 Medicare beneficiaries, totaling 6,679 services with total Medicare billing of $384,961. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location West Hollywood, CA
- Active Since 09/09/2014
- Last Updated 06/12/2017
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609277649
Products in Payments
- Vitrakvi (Drug) $88,727
- RYBREVANT (Drug) $17,346
- LYNPARZA (Drug) $13,495
- LUMAKRAS (Drug) $13,292
- TAGRISSO (Drug) $3,573
- TALZENNA (Drug) $1,800
- RETEVMO (Drug) $1,338
- Non-Covered $960.00
- Ion Torrent Semiconductor Sequencing (Device) $421.87
- cobas 8000 Core Unit (Device) $183.12
- cobas 6000 Core Unit (Device) $162.11
- MD Microbiology (Device) $127.67
- ERLEADA (Drug) $107.89
- ENHERTU (Biological) $105.12
- AVENIO Millisect (Device) $100.73
- Cellsearch (Device) $100.00
- KEYTRUDA (Biological) $100.00
- Vectibix (Biological) $95.25
- Aliqopa (Drug) $38.90
- STRYKER (Device) $38.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in West Hollywood
Joanna Xie, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $143,585
Oksana Volod, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $90,296
Alberto Marchevsky, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $5,476
Dr. Mercury Lin, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $478.10
Saleh Heneidi, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $302.44
Mariza De Peralta-Venturina
Anatomic Pathology & Clinical Pathology — Payments: $163.66